Effect of hydrocortisone on death, organ support in patients with severe COVID-19

(JAMA Network) This randomized clinical trial of patients with severe COVID-19 was stopped early after results from   another trial were released but this study investigated whether   intravenous hydrocortisone (administered either as a seven-day fixed-dose course or restricted to when shock is clinically evident) improved 21-day organ support-free days.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news